IMVT Operating Expenses

Immunovant Inc · Operating Expenses

IMVT logo

IMVT Operating Expenses

Latest reported$160.32M
IMVT Quarterly Operating Expenses ($4.37M → $160.32M)
High-resolution chart · PNG

IMVT operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunovant Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
160,323,000
159,554,000
114,362,000
131,762,000
127,224,000
113,825,000
114,302,000
115,743,000
94,281,000
80,879,000
61,553,000
61,800,000
65,977,000
64,259,000
54,027,000
49,614,000
40,375,000
47,227,000
41,271,000
37,650,000
29,886,000
28,917,000
31,640,000
20,974,000
26,586,000
20,483,000
11,041,000
419,757
92,342
450
8,841,432
6,345,995
4,368,384
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.